Comparative Study
[Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients]
[Article in
Russian]
- PMID: 147797
Item in Clipboard
Comparative Study
[Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients]
[Article in
Russian]
Genetika.
1977.
Abstract
The activity of cytoplasmic superoxydase (SOD-1) was studied in erthrocytes of 17 patients affected with Down's syndrome (trisomy 21) and in 26 healthy persons. A 1.56-fold increase of the enzyme activity was observed in the group of patients as compared with the control group. This could be explained as the dosage effect of the corresponding gene located in the chromosome 21.
Similar articles
-
Increased superoxide dismutase and Down's syndrome.Med Hypotheses. 2001 Jun;56(6):617-9. doi: 10.1054/mehy.2001.1327. Med Hypotheses. 2001. PMID: 11399108
-
Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).Lab Invest. 1996 Mar;74(3):617-26. Lab Invest. 1996. PMID: 8600312
-
Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.J Physiol (Paris). 1990;84(1):53-77. J Physiol (Paris). 1990. PMID: 1972759
-
Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.APMIS Suppl. 1993;40:71-9. APMIS Suppl. 1993. PMID: 8311993 Review.
-
[Effect of gene dose in human cells].Tsitol Genet. 1978 Jul-Aug;12(4):362-70. Tsitol Genet. 1978. PMID: 151956 Review. Russian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous